Hollings Home  
 
Graham W Warren, MD, PhD
Associate Professor of Radiation Oncology
College of Medicine
MUSC

Email: warrengw@musc.edu
 
       Print This Page
       
 
 


 

Graham W Warren, MD, PhD

Return to Search Page  

Research Interest:

I am a Board Certified radiation oncologist with a PhD in Toxicology, and my primary research interest is in evaluating the effects of tobacco and tobacco-related products on therapeutic response in cancer patients.  My research approach involves evaluation of how exposures alter tumor biology in preclinical basic laboratory systems, evaluating the epidemiology and health behaviors related to tobacco use and other exposures by cancer patients, the clinical effects of exposure to tobacco on therapeutic response as well as both cancer-related and non-cancer related health outcomes, evaluating the cost-based outcomes of tobacco and cessation on cancer treatment, and policy considerations for standard clinical practice and clinical trials design. 

Positions:
Medical Director, Tobacco Assessment and Cessation Program, Hollings Cancer Center, Medical University of South Carolina
Vice Chair for Research, Department of Radiation Oncology, Medical University of South Carolina

Selected Publications:

1.Warren GW, Dibaj S, Hutson A, Cummings KM, Dresler C, Marshall JR. Identifying Targeted Strategies to Improve Smoking Cessation Support for Cancer Patients. J Thorac Oncol. .10(11):1532-7, 2015.
View in: PubMed

2.Warren GW, Dibaj S, Hutson A, Cummings KM, Dresler C, Marshall JR. Identifying Targeted Strategies to Improve Smoking Cessation Support for Cancer Patients. J Thorac Oncol. .10(11):1532-7, 2015.
View in: PubMed

3.Warren GW, Ward KD. Integration of tobacco cessation services into multidisciplinary lung cancer care: rationale, state of the art, and future directions. Transl Lung Cancer Res. .4(4):339-52, 2015. PMCID: PMC4549462
View in: PubMed

4.Warren GW, Ward KD. Integration of tobacco cessation services into multidisciplinary lung cancer care: rationale, state of the art, and future directions. Transl Lung Cancer Res. .4(4):339-52, 2015. PMCID: PMC4549462
View in: PubMed

5.Alberg AJ, Worley ML, Tooze JA, Hatcher JL, Carpenter MJ, Day TA, Sullivan CA, Warren GW, Sterba KR, Weaver KE. The Validity of Self-reported Recent Smoking in Head and Neck Cancer Surgical Patients. Otolaryngol Head Neck Surg. ., 2015.
View in: PubMed

6.Dobson Amato KA, Hyland A, Reed R, Mahoney MC, Marshall J, Giovino G, Bansal-Travers M, Ochs-Balcom HM, Zevon MA, Cummings KM, Nwogu C, Singh AK, Chen H, Warren GW, Reid M. Tobacco Cessation May Improve Lung Cancer Patient Survival. J Thorac Oncol. .10(7):1014-9, 2015. PMCID: PMC4494894
View in: PubMed

7.Cummings KM, Gustafson JW, Sales DJ, Khuri FR, Warren GW. Business as usual is not acceptable. Cancer. .121(17):2864-5, 2015.
View in: PubMed

8.Balasubramanian S, Janech MG, Warren GW. Alterations in Salivary Proteome following Single Twenty-Minute Session of Yogic Breathing. Evid Based Complement Alternat Med. .2015:376029, 2015. PMCID: PMC4383272
View in: PubMed

9.Brandon TH, Goniewicz ML, Hanna NH, Hatsukami DK, Herbst RS, Hobin JA, Ostroff JS, Shields PG, Toll BA, Tyne CA, Viswanath K, Warren GW. Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology. Clin Cancer Res. .21(3):514-25, 2015.
View in: PubMed

10.Brandon TH, Goniewicz ML, Hanna NH, Hatsukami DK, Herbst RS, Hobin JA, Ostroff JS, Shields PG, Toll BA, Tyne CA, Viswanath K, Warren GW. Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology. J Clin Oncol. .33(8):952-63, 2015.
View in: PubMed

11.Warren GW, Sobus S, Gritz ER. The biological and clinical effects of smoking by patients with cancer and strategies to implement evidence-based tobacco cessation support. Lancet Oncol. .15(12):e568-80, 2014.
View in: PubMed

12.Sobus SL, Warren GW. The biologic effects of cigarette smoke on cancer cells. Cancer. .120(23):3617-26, 2014.
View in: PubMed

13.Warren GW. Cigarette smoking and systemic therapy for lung cancer: considering the evidence to improve cancer care. J Thorac Oncol. .9(7):914-6, 2014.
View in: PubMed

14.Warren GW, Marshall JR, Cummings KM, Singh AK, Reid ME. How can patients who are not referred for treatment receive the best treatment available? Cancer. .120(11):1750-1, 2014.
View in: PubMed

15.Warren GW, Marshall JR, Cummings KM, Singh AK, Reid ME. How can patients who are not referred for treatment receive the best treatment available? Cancer. .120(11):1750-1, 2014.
View in: PubMed

16.Cummings KM, Dresler CM, Field JK, Fox J, Gritz ER, Hanna NH, Ikeda N, Jassem J, Mulshine JL, Peters MJ, Yamaguchi NH, Warren G, Zhou C. E-cigarettes and cancer patients. J Thorac Oncol. .9(4):438-41, 2014. PMCID: PMC4040965
View in: PubMed

17.Warren GW, Alberg AJ, Kraft AS, Cummings KM. The 2014 Surgeon General's report: "The health consequences of smoking--50 years of progress": a paradigm shift in cancer care. Cancer. .120(13):1914-6, 2014.
View in: PubMed

18.Gritz ER, Toll BA, Warren GW. Tobacco use in the oncology setting: advancing clinical practice and research. Cancer Epidemiol Biomarkers Prev. .23(1):3-9, 2014. PMCID: PMC3893715
View in: PubMed

19.Balogh EP, Dresler C, Fleury ME, Gritz ER, Kean TJ, Myers ML, Nass SJ, Nevidjon B, Toll BA, Warren GW, Herbst RS. Reducing tobacco-related cancer incidence and mortality: summary of an institute of medicine workshop. Oncologist. .19(1):21-31, 2013. PMCID: PMC3903060
View in: PubMed

20.Yang GY, Malik NK, Chandrasekhar R, Ma WW, Flaherty L, Iyer R, Kuvshinoff B, Gibbs J, Wilding G, Warren G, May KS. Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer. J Gastrointest Oncol. .4(4):361-9, 2013. PMCID: PMC3819784
View in: PubMed

21.Yang GY, Malik NK, Chandrasekhar R, Ma WW, Flaherty L, Iyer R, Kuvshinoff B, Gibbs J, Wilding G, Warren G, May KS. Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer. J Gastrointest Oncol. .4(4):361-9, 2013. PMCID: PMC3819784
View in: PubMed

22.Warren GW, Marshall JR, Cummings KM, Zevon MA, Reed R, Hysert P, Mahoney MC, Hyland AJ, Nwogu C, Demmy T, Dexter E, Kelly M, O'Connor RJ, Houstin T, Jenkins D, Germain P, Singh AK, Epstein J, Dobson Amato KA, Reid ME. Automated tobacco assessment and cessation support for cancer patients. Cancer. .120(4):562-9, 2013. PMCID: PMC4482255
View in: PubMed

23.Jayaprakash V, Merzianu M, Warren GW, Arshad H, Hicks WL, Rigual NR, Sullivan MA, Seshadri M, Marshall JR, Cohan DM, Zhao Y, Singh AK. Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database. Head Neck. .36(5):694-701, 2013. PMCID: PMC4524549
View in: PubMed

24.Jayaprakash V, Merzianu M, Warren GW, Arshad H, Hicks WL, Rigual NR, Sullivan MA, Seshadri M, Marshall JR, Cohan DM, Zhao Y, Singh AK. Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database. Head Neck. .36(5):694-701, 2013. PMCID: PMC4524549
View in: PubMed

25.Kukar M, Groman A, Malhotra U, Warren GW, Bogner P, Nwogu CE, Demmy TL, Yendamuri S. Small cell carcinoma of the esophagus: a SEER database analysis. Ann Surg Oncol. .20(13):4239-44, 2013.
View in: PubMed

26.Kukar M, Groman A, Malhotra U, Warren GW, Bogner P, Nwogu CE, Demmy TL, Yendamuri S. Small cell carcinoma of the esophagus: a SEER database analysis. Ann Surg Oncol. .20(13):4239-44, 2013.
View in: PubMed

27.Warren GW, Marshall JR, Cummings KM, Toll BA, Gritz ER, Hutson A, Dibaj S, Herbst R, Mulshine JL, Hanna N, Dresler CA. Addressing tobacco use in patients with cancer: a survey of American Society of Clinical Oncology members. J Oncol Pract. .9(5):258-62, 2013. PMCID: PMC3770508
View in: PubMed

28.Platek ME, Myrick E, McCloskey SA, Gupta V, Reid ME, Wilding GE, Cohan D, Arshad H, Rigual NR, Hicks WL, Sullivan M, Warren GW, Singh AK. Pretreatment weight status and weight loss among head and neck cancer patients receiving definitive concurrent chemoradiation therapy: implications for nutrition integrated treatment pathways. Support Care Cancer. .21(10):2825-33, 2013.
View in: PubMed

29.Platek ME, Myrick E, McCloskey SA, Gupta V, Reid ME, Wilding GE, Cohan D, Arshad H, Rigual NR, Hicks WL, Sullivan M, Warren GW, Singh AK. Pretreatment weight status and weight loss among head and neck cancer patients receiving definitive concurrent chemoradiation therapy: implications for nutrition integrated treatment pathways. Support Care Cancer. .21(10):2825-33, 2013.
View in: PubMed

30.Platz TA, Nurkin SJ, Fong MK, Groman A, Flaherty L, Malhotra U, Levea CM, Yendamuri S, Warren GW, Nava HR, May KS. Neoadjuvant chemoradiotherapy for esophageal/gastroesophageal carcinoma. J Gastrointest Oncol. .4(2):137-43, 2013. PMCID: PMC3635186
View in: PubMed

31.Platz TA, Nurkin SJ, Fong MK, Groman A, Flaherty L, Malhotra U, Levea CM, Yendamuri S, Warren GW, Nava HR, May KS. Neoadjuvant chemoradiotherapy for esophageal/gastroesophageal carcinoma. J Gastrointest Oncol. .4(2):137-43, 2013. PMCID: PMC3635186
View in: PubMed

32.Yendamuri S, Huang M, Malhotra U, Warren GW, Bogner PN, Nwogu CE, Groman A, Demmy TL. Prognostic implications of signet ring cell histology in esophageal adenocarcinoma. Cancer. .119(17):3156-61, 2013.
View in: PubMed

33.Yendamuri S, Huang M, Malhotra U, Warren GW, Bogner PN, Nwogu CE, Groman A, Demmy TL. Prognostic implications of signet ring cell histology in esophageal adenocarcinoma. Cancer. .119(17):3156-61, 2013.
View in: PubMed

34.Warren GW, Marshall JR, Cummings KM, Toll B, Gritz ER, Hutson A, Dibaj S, Herbst R, Dresler C. Practice patterns and perceptions of thoracic oncology providers on tobacco use and cessation in cancer patients. J Thorac Oncol. .8(5):543-8, 2013. PMCID: PMC3628367
View in: PubMed

35.Toll BA, Brandon TH, Gritz ER, Warren GW, Herbst RS. Assessing tobacco use by cancer patients and facilitating cessation: an American Association for Cancer Research policy statement. Clin Cancer Res. .19(8):1941-8, 2013.
View in: PubMed

36.Toll BA, Brandon TH, Gritz ER, Warren GW, Herbst RS. Assessing tobacco use by cancer patients and facilitating cessation: an American Association for Cancer Research policy statement. Clin Cancer Res. .19(8):1941-8, 2013.
View in: PubMed

37.Morales NA, Romano MA, Michael Cummings K, Marshall JR, Hyland AJ, Hutson A, Warren GW. Accuracy of self-reported tobacco use in newly diagnosed cancer patients. Cancer Causes Control. .24(6):1223-30, 2013. PMCID: PMC4477518
View in: PubMed

38.Morales NA, Romano MA, Michael Cummings K, Marshall JR, Hyland AJ, Hutson A, Warren GW. Accuracy of self-reported tobacco use in newly diagnosed cancer patients. Cancer Causes Control. .24(6):1223-30, 2013. PMCID: PMC4477518
View in: PubMed

39.Warren GW, Singh AK. Nicotine and lung cancer. J Carcinog. .12:1, 2013. PMCID: PMC3622363
View in: PubMed

40.Warren GW, Cummings KM. Tobacco and lung cancer: risks, trends, and outcomes in patients with cancer. Am Soc Clin Oncol Educ Book. .359-64, 2013.
View in: PubMed

41.Fung SF, Warren GW, Singh AK. Hope for progress after 40 years of futility? Novel approaches in the treatment of advanced stage III and IV non-small-cell-lung cancer: Stereotactic body radiation therapy, mediastinal lymphadenectomy, and novel systemic therapy. J Carcinog. .11:20, 2012. PMCID: PMC3548357
View in: PubMed

42.Malik NK, May KS, Chandrasekhar R, Wee W, Flaherty L, Iyer R, Gibbs J, Kuvshinoff B, Wilding G, Warren G, Yang GY. Treatment of locally advanced unresectable pancreatic cancer: a 10-year experience. J Gastrointest Oncol. .3(4):326-34, 2012. PMCID: PMC3492478
View in: PubMed

43.Warren GW, Reid ME, Cummings KM, Marshall JR. Author's reply to: Smoking at diagnosis and survival in cancer patients. Int J Cancer. .132(4):992, 2012.
View in: PubMed

44.Warren GW, Reid ME, Cummings KM, Marshall JR. Author's reply to: Smoking at diagnosis and survival in cancer patients. Int J Cancer. .132(4):992, 2012.
View in: PubMed

45.Idris I, Warren G, Donnelly R. Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes. Arch Intern Med. .172(13):1005-11, 2012.
View in: PubMed

46.Idris I, Warren G, Donnelly R. Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes. Arch Intern Med. .172(13):1005-11, 2012.
View in: PubMed

47.Peters EN, Torres E, Toll BA, Cummings KM, Gritz ER, Hyland A, Herbst RS, Marshall JR, Warren GW. Tobacco assessment in actively accruing National Cancer Institute Cooperative Group Program Clinical Trials. J Clin Oncol. .30(23):2869-75, 2012. PMCID: PMC3410402
View in: PubMed

48.Schmitt JD, Warren GW, Wang IZ. Potential increase in biological effectiveness from field timing optimization for stereotactic body radiation therapy. Med Phys. .39(6):2956-63, 2012.
View in: PubMed

49.Platek ME, McCloskey SA, Cruz M, Burke MS, Reid ME, Wilding GE, Rigual NR, Popat SR, Loree TR, Gupta V, Warren GW, Sullivan M, Hicks WL, Singh AK. Quantification of the effect of treatment duration on local-regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck. Head Neck. .35(5):684-8, 2012.
View in: PubMed

50.Warren GW, Kasza KA, Reid ME, Cummings KM, Marshall JR. Smoking at diagnosis and survival in cancer patients. Int J Cancer. .132(2):401-10, 2012.
View in: PubMed

51.Warren GW, Romano MA, Kudrimoti MR, Randall ME, McGarry RC, Singh AK, Rangnekar VM. Nicotinic modulation of therapeutic response in vitro and in vivo. Int J Cancer. .131(11):2519-27, 2012.
View in: PubMed

52.Fung-Kee-Fung SD, Hackett R, Hales L, Warren G, Singh AK. A prospective trial of volumetric intensity-modulated arc therapy vs conventional intensity modulated radiation therapy in advanced head and neck cancer. World J Clin Oncol. .3(4):57-62, 2012. PMCID: PMC3341741
View in: PubMed

53.Fung-Kee-Fung SD, Hackett R, Hales L, Warren G, Singh AK. A prospective trial of volumetric intensity-modulated arc therapy vs conventional intensity modulated radiation therapy in advanced head and neck cancer. World J Clin Oncol. .3(4):57-62, 2012. PMCID: PMC3341741
View in: PubMed

54.Warren GW, Arnold SM, Valentino JP, Gal TJ, Hyland AJ, Singh AK, Rangnekar VM, Cummings KM, Marshall JR, Kudrimoti MR. Accuracy of self-reported tobacco assessments in a head and neck cancer treatment population. Radiother Oncol. .103(1):45-8, 2011. PMCID: PMC3327779
View in: PubMed

55.Martin KL, Gomez J, Nazareth DP, Warren GW, Singh AK. Quantification of incidental mediastinal and hilar irradiation delivered during definitive stereotactic body radiation therapy for peripheral non-small cell lung cancer. Med Dosim. .37(2):182-5, 2011.
View in: PubMed

56.Gosselin MH, Mahoney MC, Cummings KM, Loree TR, Sullivan M, King BA, Warren G, Hyland A. Evaluation of an intervention to enhance the delivery of smoking cessation services to patients with cancer. J Cancer Educ. .26(3):577-82, 2011.
View in: PubMed

57.Saddoughi SA, Garrett-Mayer E, Chaudhary U, O'Brien PE, Afrin LB, Day TA, Gillespie MB, Sharma AK, Wilhoit CS, Bostick R, Senkal CE, Hannun YA, Bielawski J, Simon GR, Shirai K, Ogretmen B. Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C18-ceramide as a novel biomarker for monitoring response. Clin Cancer Res. .17(18):6097-105, 2011. PMCID: PMC3176980
View in: PubMed

58.Platek ME, Merzianu M, Mashtare TL, Popat SR, Rigual NR, Warren GW, Singh AK. Improved survival following surgery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database. Radiat Oncol. .6:41, 2011. PMCID: PMC3098784
View in: PubMed

59.Platek ME, Reid ME, Wilding GE, Jaggernauth W, Rigual NR, Hicks WL, Popat SR, Warren GW, Sullivan M, Thorstad WL, Khan MK, Loree TR, Singh AK. Pretreatment nutritional status and locoregional failure of patients with head and neck cancer undergoing definitive concurrent chemoradiation therapy. Head Neck. .33(11):1561-8, 2010. PMCID: PMC4403643
View in: PubMed

60.Walters FS, deFontes CM, Hart H, Warren GW, Chen JS. Lepidopteran-active variable-region sequence imparts coleopteran activity in eCry3.1Ab, an engineered Bacillus thuringiensis hybrid insecticidal protein. Appl Environ Microbiol. .76(10):3082-8, 2010. PMCID: PMC2869115
View in: PubMed

61.Yelinek JT, He CY, Warren G. Ultrastructural study of Golgi duplication in Trypanosoma brucei. Traffic. .10(3):300-6, 2009.
View in: PubMed

62.Yelinek JT, He CY, Warren G. Ultrastructural study of Golgi duplication in Trypanosoma brucei. Traffic. .10(3):300-6, 2009.
View in: PubMed

63.Jucovic M, Walters FS, Warren GW, Palekar NV, Chen JS. From enzyme to zymogen: engineering Vip2, an ADP-ribosyltransferase from Bacillus cereus, for conditional toxicity. Protein Eng Des Sel. .21(10):631-8, 2008.
View in: PubMed

64.Satoh A, Warren G. In situ cleavage of the acidic domain from the p115 tether inhibits exocytic transport. Traffic. .9(9):1522-9, 2008. PMCID: PMC3035718
View in: PubMed

65.Satoh A, Warren G. In situ cleavage of the acidic domain from the p115 tether inhibits exocytic transport. Traffic. .9(9):1522-9, 2008. PMCID: PMC3035718
View in: PubMed

66.de Graffenried CL, Ho HH, Warren G. Polo-like kinase is required for Golgi and bilobe biogenesis in Trypanosoma brucei. J Cell Biol. .181(3):431-8, 2008. PMCID: PMC2364693
View in: PubMed

67.de Graffenried CL, Ho HH, Warren G. Polo-like kinase is required for Golgi and bilobe biogenesis in Trypanosoma brucei. J Cell Biol. .181(3):431-8, 2008. PMCID: PMC2364693
View in: PubMed

68.Sun Y, St Clair DK, Fang F, Warren GW, Rangnekar VM, Crooks PA, St Clair WH. The radiosensitization effect of parthenolide in prostate cancer cells is mediated by nuclear factor-kappaB inhibition and enhanced by the presence of PTEN. Mol Cancer Ther. .6(9):2477-86, 2007. PMCID: PMC2627774
View in: PubMed

69.Shirai K, O'Brien PE. Molecular targets in squamous cell carcinoma of the head and neck. Curr Treat Options Oncol. .8(3):239-51, 2007.
View in: PubMed

70.Gniadek TJ, Warren G. WatershedCounting3D: a new method for segmenting and counting punctate structures from confocal image data. Traffic. .8(4):339-46, 2007.
View in: PubMed

71.Gniadek TJ, Warren G. WatershedCounting3D: a new method for segmenting and counting punctate structures from confocal image data. Traffic. .8(4):339-46, 2007.
View in: PubMed

72.Grimes KR, Warren GW, Fang F, Xu Y, St Clair WH. Cyclooxygenase-2 inhibitor, nimesulide, improves radiation treatment against non-small cell lung cancer both in vitro and in vivo. Oncol Rep. .16(4):771-6, 2006.
View in: PubMed

73.Ho HH, He CY, de Graffenried CL, Murrells LJ, Warren G. Ordered assembly of the duplicating Golgi in Trypanosoma brucei. Proc Natl Acad Sci U S A. .103(20):7676-81, 2006. PMCID: PMC1472504
View in: PubMed

74.Ho HH, He CY, de Graffenried CL, Murrells LJ, Warren G. Ordered assembly of the duplicating Golgi in Trypanosoma brucei. Proc Natl Acad Sci U S A. .103(20):7676-81, 2006. PMCID: PMC1472504
View in: PubMed

75.He CY, Pypaert M, Warren G. Golgi duplication in Trypanosoma brucei requires Centrin2. Science. .310(5751):1196-8, 2005.
View in: PubMed

76.He CY, Pypaert M, Warren G. Golgi duplication in Trypanosoma brucei requires Centrin2. Science. .310(5751):1196-8, 2005.
View in: PubMed

77.Hartmann J, Hu K, He CY, Pelletier L, Roos DS, Warren G. Golgi and centrosome cycles in Toxoplasma gondii. Mol Biochem Parasitol. .145(1):125-7, 2005.
View in: PubMed

78.Hartmann J, Hu K, He CY, Pelletier L, Roos DS, Warren G. Golgi and centrosome cycles in Toxoplasma gondii. Mol Biochem Parasitol. .145(1):125-7, 2005.
View in: PubMed

79.Malsam J, Satoh A, Pelletier L, Warren G. Golgin tethers define subpopulations of COPI vesicles. Science. .307(5712):1095-8, 2005.
View in: PubMed

80.Malsam J, Satoh A, Pelletier L, Warren G. Golgin tethers define subpopulations of COPI vesicles. Science. .307(5712):1095-8, 2005.
View in: PubMed

81.Satoh A, Malsam J, Warren G. Tethering assays for COPI vesicles mediated by golgins. Methods Enzymol. .404:125-34, 2005.
View in: PubMed

82.Satoh A, Beard M, Warren G. Preparation and characterization of recombinant golgin tethers. Methods Enzymol. .404:279-96, 2005.
View in: PubMed

83.Satoh A, Malsam J, Warren G. Tethering assays for COPI vesicles mediated by golgins. Methods Enzymol. .404:125-34, 2005.
View in: PubMed

84.Satoh A, Beard M, Warren G. Preparation and characterization of recombinant golgin tethers. Methods Enzymol. .404:279-96, 2005.
View in: PubMed

85.Wang Y, Satoh A, Warren G. Mapping the functional domains of the Golgi stacking factor GRASP65. J Biol Chem. .280(6):4921-8, 2004. PMCID: PMC4443495
View in: PubMed

86.Wang Y, Satoh A, Warren G. Mapping the functional domains of the Golgi stacking factor GRASP65. J Biol Chem. .280(6):4921-8, 2004. PMCID: PMC4443495
View in: PubMed

87.Ang AL, Taguchi T, Francis S, Fölsch H, Murrells LJ, Pypaert M, Warren G, Mellman I. Recycling endosomes can serve as intermediates during transport from the Golgi to the plasma membrane of MDCK cells. J Cell Biol. .167(3):531-43, 2004. PMCID: PMC2172492
View in: PubMed

88.Ang AL, Taguchi T, Francis S, Fölsch H, Murrells LJ, Pypaert M, Warren G, Mellman I. Recycling endosomes can serve as intermediates during transport from the Golgi to the plasma membrane of MDCK cells. J Cell Biol. .167(3):531-43, 2004. PMCID: PMC2172492
View in: PubMed

89.He CY, Ho HH, Malsam J, Chalouni C, West CM, Ullu E, Toomre D, Warren G. Golgi duplication in Trypanosoma brucei. J Cell Biol. .165(3):313-21, 2004. PMCID: PMC2172185
View in: PubMed

90.He CY, Ho HH, Malsam J, Chalouni C, West CM, Ullu E, Toomre D, Warren G. Golgi duplication in Trypanosoma brucei. J Cell Biol. .165(3):313-21, 2004. PMCID: PMC2172185
View in: PubMed

91.Mitra K, Ubarretxena-Belandia I, Taguchi T, Warren G, Engelman DM. Modulation of the bilayer thickness of exocytic pathway membranes by membrane proteins rather than cholesterol. Proc Natl Acad Sci U S A. .101(12):4083-8, 2004. PMCID: PMC384699
View in: PubMed

92.Mitra K, Ubarretxena-Belandia I, Taguchi T, Warren G, Engelman DM. Modulation of the bilayer thickness of exocytic pathway membranes by membrane proteins rather than cholesterol. Proc Natl Acad Sci U S A. .101(12):4083-8, 2004. PMCID: PMC384699
View in: PubMed

93.Axelsson MA, Warren G. Rapid, endoplasmic reticulum-independent diffusion of the mitotic Golgi haze. Mol Biol Cell. .15(4):1843-52, 2004. PMCID: PMC379280
View in: PubMed

94.Axelsson MA, Warren G. Rapid, endoplasmic reticulum-independent diffusion of the mitotic Golgi haze. Mol Biol Cell. .15(4):1843-52, 2004. PMCID: PMC379280
View in: PubMed

95.Wang Y, Seemann J, Pypaert M, Shorter J, Warren G. A direct role for GRASP65 as a mitotically regulated Golgi stacking factor. EMBO J. .22(13):3279-90, 2003. PMCID: PMC165642
View in: PubMed

96.Wang Y, Seemann J, Pypaert M, Shorter J, Warren G. A direct role for GRASP65 as a mitotically regulated Golgi stacking factor. EMBO J. .22(13):3279-90, 2003. PMCID: PMC165642
View in: PubMed

97.Taguchi T, Pypaert M, Warren G. Biochemical sub-fractionation of the mammalian Golgi apparatus. Traffic. .4(5):344-52, 2003.
View in: PubMed

98.Taguchi T, Pypaert M, Warren G. Biochemical sub-fractionation of the mammalian Golgi apparatus. Traffic. .4(5):344-52, 2003.
View in: PubMed

99.Satoh A, Wang Y, Malsam J, Beard MB, Warren G. Golgin-84 is a rab1 binding partner involved in Golgi structure. Traffic. .4(3):153-61, 2003. PMCID: PMC3282115
View in: PubMed

100.Satoh A, Wang Y, Malsam J, Beard MB, Warren G. Golgin-84 is a rab1 binding partner involved in Golgi structure. Traffic. .4(3):153-61, 2003. PMCID: PMC3282115
View in: PubMed

101.Meyer HH, Wang Y, Warren G. Direct binding of ubiquitin conjugates by the mammalian p97 adaptor complexes, p47 and Ufd1-Npl4. EMBO J. .21(21):5645-52, 2002. PMCID: PMC131076
View in: PubMed

102.Meyer HH, Wang Y, Warren G. Direct binding of ubiquitin conjugates by the mammalian p97 adaptor complexes, p47 and Ufd1-Npl4. EMBO J. .21(21):5645-52, 2002. PMCID: PMC131076
View in: PubMed

103.Pelletier L, Stern CA, Pypaert M, Sheff D, Ngô HM, Roper N, He CY, Hu K, Toomre D, Coppens I, Roos DS, Joiner KA, Warren G. Golgi biogenesis in Toxoplasma gondii. Nature. .418(6897):548-52, 2002.
View in: PubMed

104.Pelletier L, Stern CA, Pypaert M, Sheff D, Ngô HM, Roper N, He CY, Hu K, Toomre D, Coppens I, Roos DS, Joiner KA, Warren G. Golgi biogenesis in Toxoplasma gondii. Nature. .418(6897):548-52, 2002.
View in: PubMed

105.Shorter J, Beard MB, Seemann J, Dirac-Svejstrup AB, Warren G. Sequential tethering of Golgins and catalysis of SNAREpin assembly by the vesicle-tethering protein p115. J Cell Biol. .157(1):45-62, 2002. PMCID: PMC2173270
View in: PubMed

106.Shorter J, Beard MB, Seemann J, Dirac-Svejstrup AB, Warren G. Sequential tethering of Golgins and catalysis of SNAREpin assembly by the vesicle-tethering protein p115. J Cell Biol. .157(1):45-62, 2002. PMCID: PMC2173270
View in: PubMed

107.Sheff D, Pelletier L, O'Connell CB, Warren G, Mellman I. Transferrin receptor recycling in the absence of perinuclear recycling endosomes. J Cell Biol. .156(5):797-804, 2002. PMCID: PMC2173326
View in: PubMed

108.Sheff D, Pelletier L, O'Connell CB, Warren G, Mellman I. Transferrin receptor recycling in the absence of perinuclear recycling endosomes. J Cell Biol. .156(5):797-804, 2002. PMCID: PMC2173326
View in: PubMed

109.Seemann J, Pypaert M, Taguchi T, Malsam J, Warren G. Partitioning of the matrix fraction of the Golgi apparatus during mitosis in animal cells. Science. .295(5556):848-51, 2002.
View in: PubMed

110.Seemann J, Pypaert M, Taguchi T, Malsam J, Warren G. Partitioning of the matrix fraction of the Golgi apparatus during mitosis in animal cells. Science. .295(5556):848-51, 2002.
View in: PubMed

111.Blouin RA, Warren GW. Pharmacokinetic considerations in obesity. J Pharm Sci. .88(1):1-7, 1999.
View in: PubMed